参考文章(29)
Kimmie Ng, Andrew X. Zhu, Targeting the epidermal growth factor receptor in metastatic colorectal cancer. Critical Reviews in Oncology Hematology. ,vol. 65, pp. 8- 20 ,(2008) , 10.1016/J.CRITREVONC.2007.09.006
Carla Oliveira, Mafalda Pinto, Alex Duval, Caroline Brennetot, Enric Domingo, Eloi Espín, Manel Armengol, Hiroyuki Yamamoto, Richard Hamelin, Raquel Seruca, Simó Schwartz, BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene. ,vol. 22, pp. 9192- 9196 ,(2003) , 10.1038/SJ.ONC.1207061
F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy, M P Galais, L Bastit, A Killian, R Sesboüé, J J Tuech, A M Queuniet, B Paillot, J C Sabourin, F Michot, P Michel, T Frebourg, Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. British Journal of Cancer. ,vol. 96, pp. 1166- 1169 ,(2007) , 10.1038/SJ.BJC.6603685
Sérgia Velho, Cátia Moutinho, Luís Cirnes, Cristina Albuquerque, Richard Hamelin, Fernando Schmitt, Fátima Carneiro, Carla Oliveira, Raquel Seruca, BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer. ,vol. 8, pp. 255- 255 ,(2008) , 10.1186/1471-2407-8-255
Paulo Matos, Carla Oliveira, Sérgia Velho, Vânia Gonçalves, Luís Teixiera da Costa, Mary Pat Moyer, Raquel Seruca, Peter Jordan, B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival Gastroenterology. ,vol. 135, pp. 899- 906 ,(2008) , 10.1053/J.GASTRO.2008.05.052
Sérgia Velho, Carla Oliveira, Ana Ferreira, António Carlos Ferreira, Gianpaolo Suriano, Simó Schwartz, Alex Duval, Fátima Carneiro, José Carlos Machado, Richard Hamelin, Raquel Seruca, The prevalence of PIK3CA mutations in gastric and colon cancer. European Journal of Cancer. ,vol. 41, pp. 1649- 1654 ,(2005) , 10.1016/J.EJCA.2005.04.022
Mitch Raponi, Hans Winkler, Nicholas C Dracopoli, KRAS mutations predict response to EGFR inhibitors. Current Opinion in Pharmacology. ,vol. 8, pp. 413- 418 ,(2008) , 10.1016/J.COPH.2008.06.006
A Preto, J Figueiredo, S Velho, AS Ribeiro, P Soares, C Oliveira, R Seruca, BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600E but not KRAS mutations The Journal of Pathology. ,vol. 214, pp. 320- 327 ,(2008) , 10.1002/PATH.2295
Enric Domingo, Renée C Niessen, Carla Oliveira, Pia Alhopuro, Catia Moutinho, Eloi Espín, Manel Armengol, Rolf H Sijmons, Jan H Kleibeuker, Raquel Seruca, Lauri A Aaltonen, Kohzoh Imai, Hiroyuki Yamamoto, Simó Schwartz, Robert M W Hofstra, BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene. ,vol. 24, pp. 3995- 3998 ,(2005) , 10.1038/SJ.ONC.1208569